XENOMETRIX INC \DE\
3, 1997-11-10
LABORATORY ANALYTICAL INSTRUMENTS
Previous: AMBANC HOLDING CO INC, 8-K, 1997-11-10
Next: AMERIPRIME FUNDS, 497, 1997-11-10



UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 3
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
1. Name and Address of Reporting Person
   Paramount Capital Asset Management, Inc.
   787 Seventh Avenue
   NY, NY 10019
2. Date of Event Requiring Statement (Month/Day/Year)
   10/30/97
3. IRS or Social Security Number of Reporting Person (Voluntary)
   
4. Issuer Name and Ticker or Trading Symbol
   Xenometrix, Inc. (XENO)
   
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)
   ( ) Director  (X) 10% Owner  ( ) Officer (give title below) ( ) Other
   (specify below)
   
6. If Amendment, Date of Original (Month/Day/Year)
   
7. Individual or Joint/Group Filing (Check Applicable Line)
   ( ) Form filed by One Reporting Person
   ( ) Form filed by More than One Reporting Person
<TABLE>
<CAPTION>
___________________________________________________________________________________________________________________________________
 Table I -- Non-Derivative Securities Beneficially Owned                                                                           |
___________________________________________________________________________________________________________________________________|
1. Title of Security                       |2. Amount of          |3. Ownership    |4. Nature of Indirect                          |
                                           |   Securities         |   Form:        |   Beneficial Ownership                        |
                                           |   Beneficially       |   Direct(D) or |                                               |
                                           |   Owned              |   Indirect(I)  |                                               |
___________________________________________________________________________________________________________________________________|
<S>                                        <C>                    <C>              <C>
Common Stock                               |  34,000              |   D            |                                               |
- -----------------------------------------------------------------------------------------------------------------------------------|
___________________________________________________________________________________________________________________________________|
<CAPTION>
___________________________________________________________________________________________________________________________________
 Table II -- Derivative Securitites Beneficially Owned                                                                             |
___________________________________________________________________________________________________________________________________|
1.Title of Derivative   |2.Date Exer-       |3.Title and Amount     |         |4. Conver-|5. Owner-    |6. Nature of Indirect      |
  Security              |  cisable and      |  of Underlying        |         |sion or   |ship         |   Beneficial Ownership    |
                        |  Expiration       |  Securities           |         |exercise  |Form of      |                           |
                        |  Date(Month/      |-----------------------|---------|price of  |Deriv-       |                           |
                        |  Day/Year)        |                       |Amount   |deri-     |ative        |                           |
                        | Date    | Expira- |                       |or       |vative    |Security:    |                           |
                        | Exer-   | tion    |         Title         |Number of|Security  |Direct(D) or |                           |
                        | cisable | Date    |                       |Shares   |          |Indirect(I)  |                           |
___________________________________________________________________________________________________________________________________|
<S>                     <C>       <C>       <C>                     <C>       <C>        <C>           <C>
 Warrants               | 10/25/95|10/25/00 |Common Stock           | 30,000  |$7.0875   |D            |                           |
 Warrants               | 09/25/97|09/25/02 |Common Stock           |166,665  |$2.14816  |D            |                           |
 Warrants               | 10/7/97 |10/7/02  |Common Stock           | 83,333  |$2.14816  |D            |                           |
 Warrants               | 10/21/97|10/21/02 |Common Stock           | 83,332  |$2.14816  |D            |                           |
                        |         |         |                       |         |          |             |                           |
- -----------------------------------------------------------------------------------------------------------------------------------|
___________________________________________________________________________________________________________________________________|
</TABLE>
Explanation of Responses:
See Attachment A.
SIGNATURE OF REPORTING PERSON
/s/Lindsay A. Rosenwald, M.D
- ----------------------------
Lindsay A. Rosenwald, M.D, President
Paramount Capital Asset Management, Inc. 
DATE
11/10/97

<PAGE>
                              ATTACHMENT TO FORM 3

Paramount Capital Asset Management,  Inc. ("Paramount Capital"),  is the General
Partner of the Aries Domestic Fund, L.P. (the "Partnership"),  and serves as the
investment  manager to The Aries Fund, a Cayman  Islands  trust,  (the  "Trust")
which each owns  securities of the Issuer.  Lindsay A.  Rosenwald,  M.D., is the
sole shareholder of Paramount  Capital.  Paramount Capital and Dr. Rosenwald may
be deemed to have  voting and  investment  control  over the  securities  of the
Issuer owned by the Trust and the Partnership under Rule 16a-1(a)(1).  Paramount
Capital and Dr. Rosenwald disclaim  beneficial  ownership of the securities held
by the  Partnership  and the  Trust,  except to the  extent  of their  pecuniary
interest therein, if any.



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission